SeLux Diagnostics, Inc.
SeLux’s Next Generation Phenotyping (NGP) platform provides rapid, high-throughput, fully-automated AST results, enabling same-shift susceptibility testing of up to 50 antibiotics in parallel. The platform is driven by SeLux’s proprietary assay, which differentiates antibiotic-induced bacterial growth modes with a surface-binding fluorescent amplifier.
Address
Charlestown, MA 02129
United States
United States
Website
Email
Telephone
+1-617-945-9383
Microbiology Product Areas
ClinicalNOTE: The products listed in this section may not be approved for clinical diagnostic use in your jurisdiction. You must assume these products are unregulated and therefore cannot be used for routine testing and reporting of results unless otherwise stated. | ||
| Antibiotic Resistance | Show all suppliers | |
| Antibiotic Sensitivity | Show all suppliers | |
| Antimicrobial Resistance (AMR) | Show all suppliers | |
Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!
LATEST MICROBIOLOGY NEWS
- Watch Cyclone in Action and Automate Your Microbiology Quality Control
- AFNOR Validation for Bio-Rad’s iQ-Check Listeria Protocols
- QC and Inventory Management Solutions for Clinical Microbiology Labs
- Superbug Surcharge: The Economics of MDROs and HAIs
- INTEGRA Biosciences Partners with CleanHub to Prevent Plastic Pollution
- BIOFIRE® FILMARRAY® Tropical Fever (TF) Panel Receives FDA Clearance
- The Revised EN ISO 7704:2023 is Advancing Water Quality Analysis, Is Your Lab Keeping Up?
- Water Microbiology - a rapidmicrobiology Special Focus
- Coming Soon from MicronView
- Revolutionizing Legionella pneumophila Detection in Water Microbiology